Yi Luo

Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non–Small Cell Lung Cancer

Baohui Han, Kai Li, Qiming Wang et al. · JAMA Oncology · 2018 · 591 citations · Full text

What are the Complications of Three-dimensionally Printed, Custom-made, Integrative Hemipelvic Endoprostheses in Patients with Primary Malignancies Involving the Acetabulum, and What is the Function of These Patients?

Jie Wang, Min Li, Minxun Lu et al. · Clinical Orthopaedics and Related Research · 2020 · 81 citations · Full text

pH/photothermal dual-responsive drug delivery and synergistic chemo-photothermal therapy by novel porous carbon nanofibers

Jiamu Dai, Yi Luo, Du Nie et al. · Chemical Engineering Journal · 2020 · 62 citations

Nanomedicine, Chemical Engineering, Engineering +7

Clinical evaluation for lower abdominal aorta balloon occluding in the pelvic and sacral tumor resection

Yi Luo, Hong Duan, Wanglin Liu et al. · Journal of Surgical Oncology · 2013 · 46 citations

Quality of life results from a randomized, double-blinded, placebo-controlled, multi-center phase III trial of anlotinib in patients with advanced non-small cell lung cancer

Xiaoyan Si, Li Zhang, Hanping Wang et al. · Lung Cancer · 2018 · 41 citations

Medicine, Clinical Trials, Immune Checkpoint Inhibitor +7